CJEU Overturns Neurim – no SPCs for New Therapeutic uses of Old Active Ingredients
Home / News / CJEU Overturns Neurim – no SPCs for New Therapeutic uses of Old Active Ingredients

CJEU Overturns Neurim – no SPCs for New Therapeutic uses of Old Active Ingredients

The CJEU issued on 9 July 2020 its judgment in the Santen C-673/18 case. The judgment, which is reviewed in more detail in our briefing (here), overturns the earlier Neurim decision and concludes that SPCs are not available for new therapeutic uses of old active ingredients.

If you have any concerns or queries about the impact of this decision please speak to your usual J A Kemp contact.